<DOC>
	<DOCNO>NCT02085993</DOCNO>
	<brief_summary>Cross-sectional study , observation make healthcare professional subject caregiver , administer romiplostim first standard-of-care visit 4 week train home administration train pack . Further observation also record study make within 16 week enrolment . Data collect subject ' dose diary first standard care visit ensure problem administration clinic .</brief_summary>
	<brief_title>Study Patients With ITP Estimating Proportion Administering Romiplostim Correctly After Receiving Home Administration Training</brief_title>
	<detailed_description>This cross-sectional study involve direct observation healthcare professional series subject caregiver act administer romiplostim first standard-of-care visit occur 4 week train HAT pack . Further observation , occur , also record study make within 16 week enrolment . ( Additional observation voluntary require study participation ; occur healthcare professional request . ) Additionally , data collect subject ' dose diary first standard care visit ensure problem administration clinic .</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>( 1 ) adult ITP patient , treat per EU Summary product characteristic ( SmPC ) , caregiver new ( least 3 month gap ) administer romiplostim , ( 2 ) receive HAT pack training , ( 3 ) available standardofcare medical visit 4 week ( range 2 8 week ) HAT pack training , ( 4 ) patient provide informed consent . No exclusion criterion observational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>romiplostim ,</keyword>
	<keyword>Nplate ,</keyword>
	<keyword>immune thrombocytopenic purpura</keyword>
</DOC>